MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Avalyn Pharma Inc. (AVLN)

Avalyn Pharma Inc. (AVLN)

||
||

Balance Sheets Overview

Current Ratio
3311.94%
Quick Ratio
3311.94%
Cash Ratio
2444.23%
Debt to Asset Ratio
6.37%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities, current
    • Marketable securities, noncurren...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Term loan
    • Others
Balance Sheets
2026-06-30
2026-03-31
Cash and cash equivalents
264,197
92,310
Marketable securities, current
88,228
30,817
Prepaid expenses and other current assets
5,563
6,860
Total current assets
357,988
129,987
Total property and equipment
1,422
1,373
Less accumulated depreciation
216
117
Property and equipment, net
1,206
1,256
Operating lease right-of-use asset
2,140
1,421
Marketable securities, noncurrent
61,103
-
Other assets
3,011
2,999
Total noncurrent assets
67,460
5,676
Total assets
425,448
135,663
Accounts payable
2,648
3,147
Accrued liabilities
7,345
8,133
Operating lease liability
816
507
Total current liabilities
10,809
11,787
Term loan
14,801
14,808
Operating lease liability, noncurrent
1,492
1,092
Total liabilities
27,102
27,687
Redeemable convertible preferred stock-Series APreferred Stock
0
49,176
Redeemable convertible preferred stock-Series BPreferred Stock
0
35,376
Redeemable convertible preferred stock-Series CPreferred Stock
0
174,494
Redeemable convertible preferred stock-Series C2Preferred Stock
0
13,406
Redeemable convertible preferred stock-Series DPreferred Stock
0
99,769
Common stock, 0.001 par value 700,000,000 and 575,000,000 shares authorized as of june 30, 2026 and december 31, 2025, respectively 44,333,094 and 1,227,186 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
67
24
Additional paid-in capital
719,541
27,950
Accumulated other comprehensive (loss) income
-95
12
Accumulated deficit
-321,167
-292,231
Total stockholders' equity (deficit)
398,346
-264,245
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)
425,448
135,663
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Total property andequipment$1,422K Cash and cashequivalents$264,197K Marketable securities,current$88,228K Prepaid expenses andother current assets$5,563K Marketable securities,noncurrent$61,103K Other assets$3,011K Operating leaseright-of-use asset$2,140K Property and equipment,net$1,206K Less accumulateddepreciation$216K Total current assets$357,988K Total noncurrentassets$67,460K Total assets$425,448K Total liabilities,redeemable convertible...$425,448K Total stockholders'equity (deficit)$398,346K Total liabilities$27,102K Accumulated deficit-$321,167K Accumulated othercomprehensive (loss) income-$95K Additional paid-in capital$719,541K Term loan$14,801K Total currentliabilities$10,809K Operating leaseliability, noncurrent$1,492K Common stock, 0.001 parvalue 700,000,000 and...$67K Accrued liabilities$7,345K Accounts payable$2,648K Operating lease liability$816K